Publication: OncLive
Emerging data are changing the treatment paradigm in pancreatic cancer, offering patients new options and more personalized care, according to Carlos Becerra, medical oncologist with Texas Oncology–Baylor Charles A. Sammons Cancer Center. Becerra discusses sequencing strategies, immunotherapy, and practice-changing clinical trials in the field of pancreatic cancer.
Read the full story at OncLive.